Alexander Schueller is a repeat-entrepreneur in the life sciences, having co-founded, built and successfully exited Adhesys Medical, after starting his professional career at The Boston Consulting Group.

Alex had known Pedro from his first venture and when he was introduced to therapeutic mitochondria transplantation (TMT), he was immediately captivated by the opportunity to bring about a novel category of cell-derived medicines. Alex is particularly keen to develop TMT as a platform, to realize its full potential.